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Abstract 
High levels of pharmaceuticals, including fluoroquinolones (FQs), have been detected in the 
effluent from an Indian waste water treatment plant serving bulk drug production intended 
for the global market. Responses from short-term effluent exposure were studied in fish and 
rats through explorative analyses of hepatic mRNA abundance, enzyme activities and blood 
chemistry parameters. Exposure of rainbow trout to 0.2% effluent for five days altered hepatic 
gene expression and increased Cyp1a activity as well as blood plasma phosphate and 
cholesterol. In contrast, no effects could be demonstrated in rats tube-fed with effluent. Thus, 
exposure to effluent from drug manufacturing affects aquatic wild-life. No toxic effects were 
observed in rats after short-term exposure but risks associated with higher doses of effluent or a 
longer exposure time cannot be excluded. 
High concentrations of FQs were found in sediment from the Indian river receiving drug-
contaminated effluent, while no FQs were detected in sediment sampled near a municipal 
Swedish waste water treatment plant. Metagenome sequencing showed that resistance genes 
for several classes of antibiotics as well as genetic mobility elements were enriched in Indian 
sediments compared to Swedish samples. Selected antibiotic resistance genes were studied with 
qPCR in well water and soil from Indian villages. FQs were detected in samples from villages 
located <3 km from waterways with documented drug contamination. No enrichment of 
quinolone resistance genes (qnr) were seen in FQ-contaminated well water or soil while 
differences over seasons were observed for sul2, a sulfonamide resistance gene, and intI1, a class 
1 integrase. Also, qnr were analyzed in human fecal samples. Three qnr genes were prevalent in 
fecal samples from Indians living in FQ-polluted as well as in FQ-free villages. The same three 
genes were detected, but less commonly, in stool samples from a group of Swedish students.  
In conclusion, these studies demonstrate that discharges from antibiotic production lead to 
promotion of resistance genes and mechanisms facilitating their mobility in highly 
contaminated aquatic environments. Additional studies are required to elucidate the 
consequences of lower antibiotic concentrations in well water and soil, and the risk for transfer 
of antibiotic resistance genes from environmental bacteria to human intestinal flora. Once 
established, antibiotic resistance can rapidly spread over an extensive geographical area. 
Despite current knowledge gaps, the toxicity to wildlife and potential detrimental 
consequences for human health call for immediate and collaborative actions to improve waste 
management from drug manufacturing. 
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